Research Partnership appoints Claire Richardson as Director in the US office
Research Partnership has appointed Claire Richardson as Director in the US office, bringing the total number of Directors to 18, supported by over 70 researchers.
Claire has more than 20 years of market research experience and a strong pedigree in healthcare research on both the client and agency side, having previously worked at GSK and agencies including PMSI / IMS, Quintiles and Brand Health International. Although she works across both the quantitative and qualitative research arenas, she has a particular strength in language analysis, being an NLP master practitioner. Claire is an experienced interviewer, having conducted IDIs and focus groups amongst a variety of healthcare stakeholders for both domestic and global studies.Mary Assimakopoulos, Founding Director and US lead, comments, “We are delighted to welcome Claire, a seasoned professional, to our team. This year The Research Partnership celebrates its 15th anniversary and our objective is to continue to expand our international operations and grow the business. Claire’s appointment strengthens the broad range of skills and expertise within our senior team.”
Sign up to receive Rapport Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here »
Delivering 'in-the-moment' market research to global healthcare
Published in Research World, October 2012, By John Branston, Director There have been numerous reports in the pharmaceutical and international press concerning the high rate of adoption of mobile devices amongst physicians. A survey conducted earlier this year by Manhattan Research showed that physician use of tablets for professional purposes nearly doubled last year, with 62% of doctors now using the technology. But despite advances in data collection techniques and technology over the years, pharmaceutical market researchers have not successfully developed techniques to capture immediate detailed, qualitative insights into prescription rationale at the patient level, particularly where these prescription decisions are made by hospital specialists. This is a problem that I believe mobile research is destined to overcome, because of the ‘go-anywhere’ functionality afforded by smartphone technology and because of the popularity of smartphones, specifically amongst physicians.A report by Jackson and Coker released late last year stated that four out of five practicing physicians in the US use smartphones, computer tablets, and other mobile devices during the course of their workday.It is a theory that I recently tested by working with pharmaceutical company Merck Serono. The organisation was seeking approval of its existing oncology drug Erbitux (currently licensed in colorectal…